Stay updated on Amivantamab in Esophagogastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.

Latest updates to the Amivantamab in Esophagogastric Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now lists Revision: v3.5.4 instead of v3.5.3, signaling a minor site update. No study content or critical functionality appears to be affected.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page’s footer indicates an update to the ClinicalTrials.gov interface/version (revision v3.5.3 instead of v3.5.2). This reflects a version change of the site rather than an update to the trial details.SummaryDifference0.1%

- Check36 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the site metadata.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check94 days agoChange DetectedNew update entries for 2026-02-12 and 2026-02-17 were added and older 2025 entries removed, updating the study record’s last-update information and QC status.SummaryDifference0.2%

Stay in the know with updates to Amivantamab in Esophagogastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.